by Dr. Leo Galland
A study in the December 16, 2009 Journal of the American Medical Association (JAMA) found that higher levels of the hormone leptin protected people from developing Alzheimer’s disease1. The analysis came from the famed Framingham heart study, which has been following the residents of Framingham, Massachusetts, for decades.
When they grouped people according to their sex and level of leptin, they found that among the group with the lowest leptin levels, 25% developed Alzheimer’s disease during the study period, whereas only 6% of the highest leptin group developed Alzheimer’s disease. Continue reading »
